John Oidtman

John Oidtman is a seasoned biopharmaceutical leader with extensive global management experience. Having begun their career as a toxicologist, John transitioned to leadership roles in quality and regulatory affairs, eventually serving as Chief Operating Officer and Senior Vice President at EMD Serono/Merck KGaA. John has been instrumental in managing clinical operations and regulatory affairs at Pfizer and has contributed to the successful commercialization of 21 healthcare products. Currently, John serves as an advisor for various organizations, including OnKai Inc. and Beaconcure, while also holding a board member position at TransCelerate Biopharma, Inc. John holds a BS in Zoology from the University of Maryland and furthered their business education with programs at INSEAD and Stanford University.